Health Update: Biden Begins Radiation and Hormone Therapy for Prostate Cancer

WASHINGTON — Former President Joe Biden has entered a new phase of his cancer care, beginning a combination of radiation therapy and hormone treatment to address his prostate cancer diagnosis. A spokesperson confirmed Saturday that this regimen is part of a broader treatment plan for an aggressive form of the disease, first announced in May. The move signals the progression from initial management to more intensive intervention.

Biden’s team described the cancer as “hormone-sensitive,” offering hope that the treatments could be effective despite the disease’s advanced nature. The timing also comes amid heightened public interest in his health and capacity, particularly following his exit from the 2024 presidential race and subsequent transition from public life. :contentReference[oaicite:0]{index=0}

From Diagnosis to Treatment Plan

In May 2025, Biden announced he had been diagnosed with an aggressive form of prostate cancer that had metastasized to his bones. His post-presidential office revealed that the disease carried a Gleason score of 9 (Grade Group 5), placing it among the highest-risk categories. :contentReference[oaicite:1]{index=1}

At that time, he described the cancer as “hormone-sensitive,” meaning it may respond well to treatments that suppress androgen hormones, which often fuel prostate tumor growth. :contentReference[oaicite:2]{index=2}

Biden initially began hormone therapy — in pill form — soon after the diagnosis, with the intent to slow tumor growth through androgen suppression. :contentReference[oaicite:3]{index=3} Now, the introduction of radiation therapy signals an escalation in his care plan, targeting cancer sites with precisely delivered doses of ionizing radiation.

Understanding Radiation and Hormone Therapy

Radiation therapy works by damaging the DNA of cancer cells, preventing their ability to replicate and causing cell death over time. In prostate cancer, radiation is often paired with hormonal therapy (also known as androgen deprivation therapy, or ADT) to improve outcomes, especially in high-risk or metastatic cases. :contentReference[oaicite:4]{index=4}

Hormone therapy aims to lower levels of testosterone and other androgens, which prostate cancer cells often use as a growth signal. By “starving” cancer cells of this hormonal fuel, the therapy can shrink tumors or slow their progression. :contentReference[oaicite:5]{index=5}

When deployed together, radiation and hormonal approaches have been shown to be more effective than radiation alone in certain high-risk or locally advanced cancers. Experts say that combining modalities is common in aggressive prostate cancer management. :contentReference[oaicite:6]{index=6}

Possible Side Effects and Considerations

While potentially effective, these treatments come with side effects and risks. Radiation to the pelvic area may cause urinary irritation, bowel changes, fatigue, and erectile dysfunction. Hormone therapy may bring side effects such as hot flashes, reduced libido, weight gain, bone thinning, and metabolic changes. :contentReference[oaicite:7]{index=7}

Doctors typically monitor patients closely, managing symptoms and adjusting therapy as needed. Given Biden’s age (82) and the spread of cancer to bone, his medical team faces a delicate balance of maximizing treatment efficacy while preserving quality of life.

Public and Political Implications

Biden’s health has been under increasing scrutiny in recent years, both during and after his presidency. His withdrawal from the 2024 presidential race followed a troubled debate performance, raising questions about age, stamina, and cognitive fitness. :contentReference[oaicite:8]{index=8}

The announcement of more intensive treatment inevitably fuels discussion about his public engagements, travel, and ability to continue an active role in civic life. So far, Biden has maintained a relatively low public profile, focusing on private recovery and limited appearances. :contentReference[oaicite:9]{index=9}

Support has poured in from across the political spectrum. In May, leaders and colleagues expressed well-wishes and confidence in his prognosis. :contentReference[oaicite:10]{index=10} The disclosure of his intensified treatment continues that narrative of transparency and resilience.

Expert Views: Outlook and Challenges

Medical experts caution that while hormone-sensitive prostate cancer offers treatment options, metastatic disease — especially when spread to bone — presents greater challenges. Success often depends on early detection, patient health, and response to therapy. :contentReference[oaicite:11]{index=11}

Dr. Jai Eswara, a urologist quoted by WCVB, noted that Biden’s Gleason 9 score suggests the cancer was likely present for some time before detection. He also stressed that while the treatment options are robust, side effects and continuous monitoring will be key. :contentReference[oaicite:12]{index=12}

STAT News, in coverage of the announcement, emphasized the aggressive nature of the disease but also noted that hormone sensitivity offers a pathway for meaningful medical management. :contentReference[oaicite:13]{index=13}

Ultimately, much depends on how well Biden tolerates treatment, how the disease responds, and whether any further adjustments are needed in his regimen.

Conclusion: A Critical Stage in a High-Stakes Journey

As former President Biden enters this new chapter of intensive treatment, his medical team’s choices reflect both the severity of the disease and the possibilities of modern oncology. The combination of radiation therapy and hormone suppression marks a more aggressive front in a battle already underway.

While prognosis in aggressive, metastatic prostate cancer is never assured, Biden’s case shows that even complex illnesses can be met with structured, evidence-based care. As he navigates side effects, public expectations, and personal resolve, one question remains: how effectively will his body—and spirit—respond to this renewed fight?

::contentReference[oaicite:14]{index=14}